Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.69% | 11.02% | -15.39% | -9.75% | -7.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.41% | 5.88% | -4.63% | -7.08% | -4.54% |
| Operating Income | -16.41% | -5.88% | 4.63% | 7.08% | 4.54% |
| Income Before Tax | -21.62% | -8.48% | 6.86% | 12.26% | 12.06% |
| Income Tax Expenses | -609,966.67% | -536,733.33% | -402,600.00% | -323,380.00% | 127.27% |
| Earnings from Continuing Operations | 6.49% | 14.87% | 29.06% | 34.07% | 12.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.49% | 14.87% | 29.06% | 34.07% | 12.04% |
| EBIT | -16.41% | -5.88% | 4.63% | 7.08% | 4.54% |
| EBITDA | -17.57% | -6.12% | 5.28% | 8.08% | 5.88% |
| EPS Basic | 11.14% | 21.28% | 35.95% | 40.40% | 18.34% |
| Normalized Basic EPS | -16.74% | 0.42% | 16.66% | 21.75% | 19.08% |
| EPS Diluted | 11.14% | 21.28% | 35.95% | 40.40% | 18.34% |
| Normalized Diluted EPS | -16.74% | 0.42% | 16.66% | 21.75% | 19.08% |
| Average Basic Shares Outstanding | 4.62% | 7.44% | 10.49% | 11.18% | 8.22% |
| Average Diluted Shares Outstanding | 4.62% | 7.44% | 10.49% | 11.18% | 8.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |